Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Life Science History - Page 41

Life Science History

Serum Institute of India and Dynavax announced first participants dosed in phase 1/2 clinical trial for COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Serum Institute of India and Dynavax announced first participants dosed in phase 1/2 clinical trial for COVID-19 vaccine

On Dec. 23, 2020, Serum Institute of India and Dynavax jointly announced that the first participants had been…

Read More Serum Institute of India and Dynavax announced first participants dosed in phase 1/2 clinical trial for COVID-19 vaccineContinue

VBI Vaccines announced EMA acceptance of MAA for 3-Antigen prophylactic Hepatitis B vaccine
Life Science History | Vaccine

VBI Vaccines announced EMA acceptance of MAA for 3-Antigen prophylactic Hepatitis B vaccine

On Dec. 23, 2020, VBI Vaccines announced that the European Medicines Agency (EMA) has accepted the filing of…

Read More VBI Vaccines announced EMA acceptance of MAA for 3-Antigen prophylactic Hepatitis B vaccineContinue

Altimmune provided an update on investigational New Drug Application for phase 1 AdCOVIDル clinical trial
COVID-19 | FDA | Life Science History

Altimmune provided an update on investigational New Drug Application for phase 1 AdCOVIDル clinical trial

On Dec. 23, 2020, Altimmune announced that the FDA had issued a clinical hold on the Companyメs Investigational…

Read More Altimmune provided an update on investigational New Drug Application for phase 1 AdCOVIDル clinical trialContinue

Tonix Pharmaceuticals announced commercial scale vaccine manufacturing facility in Hamilton, Montana
Life Science History | Vaccine

Tonix Pharmaceuticals announced commercial scale vaccine manufacturing facility in Hamilton, Montana

On Dec. 23, 2020, Tonix Pharmaceuticals announced that it had completed the purchase of an approximately 44-acre site…

Read More Tonix Pharmaceuticals announced commercial scale vaccine manufacturing facility in Hamilton, MontanaContinue

Pfizer and BioNTech to supply the US with 100 million additional doses of COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

Pfizer and BioNTech to supply the US with 100 million additional doses of COVID-19 vaccine

On Dec. 23, 2020, Pfizer and BioNTech announced a second agreement with the U.S. government to supply an…

Read More Pfizer and BioNTech to supply the US with 100 million additional doses of COVID-19 vaccineContinue

Resverlogix announced apabetalone treatment prior to SARS-CoV-2 exposure reduced viral infection
COVID-19 | Life Science History

Resverlogix announced apabetalone treatment prior to SARS-CoV-2 exposure reduced viral infection

On Dec. 22, 2020, Resverlogix announced published findings in the Proceedings of the National Academy of Sciences (PNAS),…

Read More Resverlogix announced apabetalone treatment prior to SARS-CoV-2 exposure reduced viral infectionContinue

NIH neuroscientists isolated promising mini antibodies against COVID-19 from a llama
Life Science History | Nanotechnology | NIH

NIH neuroscientists isolated promising mini antibodies against COVID-19 from a llama

On Dec. 22, 2020, the NIH researchers announced they had isolated a set of promising, tiny antibodies, or…

Read More NIH neuroscientists isolated promising mini antibodies against COVID-19 from a llamaContinue

NIH ACTIV Trial of blood thinners paused enrollment of critically ill COVID-19 patients
COVID-19 | Life Science History | NIH

NIH ACTIV Trial of blood thinners paused enrollment of critically ill COVID-19 patients

On Dec. 22, 2020, the NIH researchers announced that three clinical trial platforms working together to test the…

Read More NIH ACTIV Trial of blood thinners paused enrollment of critically ill COVID-19 patientsContinue

Abivax’s Covid-19 phase 2b/3 miR-AGE trial with ABX464 declared National Priority by French government
Life Science History

Abivax’s Covid-19 phase 2b/3 miR-AGE trial with ABX464 declared National Priority by French government

On Dec. 22, 2020, Abivax announced that the Companyメs ongoing ABX464 phase 2b/3 trial in high-risk Covid-19 patients…

Read More Abivax’s Covid-19 phase 2b/3 miR-AGE trial with ABX464 declared National Priority by French governmentContinue

COVID-19 targeted treatment trial launched in Vienna
COVID-19 | Life Science History

COVID-19 targeted treatment trial launched in Vienna

On Dec. 22, 2020, a phase II clinical trial of a treatment for COVID-19 patients was started at…

Read More COVID-19 targeted treatment trial launched in ViennaContinue

CDC’s ACIP updated interim recommendation for allocation of COVID-19 vaccine
COVID-19 | Life Science History | Vaccine

CDC’s ACIP updated interim recommendation for allocation of COVID-19 vaccine

On Dec. 22, 2020, the ACIP updated interim vaccine allocation recommendations. In Phase 1b, COVID-19 vaccine should be…

Read More CDC’s ACIP updated interim recommendation for allocation of COVID-19 vaccineContinue

Singapore approved sale of lab-grown meat in world first
Life Science History

Singapore approved sale of lab-grown meat in world first

On Dec. 1, 2020, the governmenrt of Singapore announced that it had given U.S. start-up Eat Just the…

Read More Singapore approved sale of lab-grown meat in world firstContinue

CureVac and University Medical Center Mainz started phase 3 clinical trial for COVID-19 vaccine candidate
COVID-19 | Life Science History | Vaccine

CureVac and University Medical Center Mainz started phase 3 clinical trial for COVID-19 vaccine candidate

On Dec. 21, 2020, CureVac announced that the first participant in a clinical Phase 3 study with its…

Read More CureVac and University Medical Center Mainz started phase 3 clinical trial for COVID-19 vaccine candidateContinue

CVS Health began administering COVID-19 vaccines in long-term care facilities
COVID-19 | Life Science History | Vaccine

CVS Health began administering COVID-19 vaccines in long-term care facilities

On Dec. 21, 2020, CVS Health announced it had formally launched its COVID-19 vaccination program for long-term care…

Read More CVS Health began administering COVID-19 vaccines in long-term care facilitiesContinue

NIH announced support of radical approaches to nationwide COVID-19 testing and surveillance
COVID-19 | Life Science History | NIH

NIH announced support of radical approaches to nationwide COVID-19 testing and surveillance

On Dec. 21, 2020, the NIH announced that it had awarded over $107 million to support new, non-traditional…

Read More NIH announced support of radical approaches to nationwide COVID-19 testing and surveillanceContinue

NIH funded eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children
COVID-19 | Environmental | Life Science History | NIH

NIH funded eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in children

On Dec. 21, 2020, the NIH announced that it had awarded eight research grants to develop approaches for…

Read More NIH funded eight studies to uncover risk factors for COVID-19-related inflammatory syndrome in childrenContinue

FDA granted IND approval for phase 2 clinical trial of Innovation Pharmasメ Brilacidin for treating COVID-19
COVID-19 | FDA | Life Science History

FDA granted IND approval for phase 2 clinical trial of Innovation Pharmasメ Brilacidin for treating COVID-19

On Dec. 21, 2020, Innovation Pharma announced that the FDA had approved the Companyメs Investigational New Drug (IND)…

Read More FDA granted IND approval for phase 2 clinical trial of Innovation Pharmasメ Brilacidin for treating COVID-19Continue

FDA granted IND approval for phase 2 clinical trial of Innovation Pharma’s Brilacidin for treating COVID-19
COVID-19 | FDA | Life Science History

FDA granted IND approval for phase 2 clinical trial of Innovation Pharma’s Brilacidin for treating COVID-19

On Dec. 21, 2020, Innovation Pharmaceuticals announced that the FDA had approved the Companyメs Investigational New Drug (IND)…

Read More FDA granted IND approval for phase 2 clinical trial of Innovation Pharma’s Brilacidin for treating COVID-19Continue

Labcorp made Pixel At-Home COVID-19 Collection Kit available through Walgreens Find Careᆴ
COVID-19 | Life Science History

Labcorp made Pixel At-Home COVID-19 Collection Kit available through Walgreens Find Careᆴ

On Dec. 21, 2020, LabCorp and Walgreens announced that the Pixel by Labcorpル At-Home COVID-19 Collection Kit is…

Read More Labcorp made Pixel At-Home COVID-19 Collection Kit available through Walgreens Find CareᆴContinue

Novan engaged Catalent to develop intranasal formulation of berdazimer sodium for COVID-19 program
COVID-19 | Life Science History

Novan engaged Catalent to develop intranasal formulation of berdazimer sodium for COVID-19 program

On Dec. 21, 2020, Novan announced it had entered into a Master Services Agreement (MSA) with Catalent, which…

Read More Novan engaged Catalent to develop intranasal formulation of berdazimer sodium for COVID-19 programContinue

Pfizer and BioNTech received CHMP positive opinion for their COVID-19 vaccine
COVID-19 | Life Science History

Pfizer and BioNTech received CHMP positive opinion for their COVID-19 vaccine

On Dec. 21, 2020, Pfizer and BioNTech announced that the Committee for Medicinal Products for Human Use (CHMP)…

Read More Pfizer and BioNTech received CHMP positive opinion for their COVID-19 vaccineContinue

Pfizer and BioNTech received authorization in the European Union for COVID-19 vaccine
COVID-19 | Life Science History

Pfizer and BioNTech received authorization in the European Union for COVID-19 vaccine

On Dec. 21, 2020, Pfizer and BioNTech announced that the European Commission (EC) had granted a conditional marketing…

Read More Pfizer and BioNTech received authorization in the European Union for COVID-19 vaccineContinue

OraSure updated Its Emergency Use Authorization application for lab-based oral SARS-CoV-2 antibody test
FDA | Life Science History

OraSure updated Its Emergency Use Authorization application for lab-based oral SARS-CoV-2 antibody test

On Dec. 21, 2020, OraSure Technologies disclosed that the FDA had requested additional information as part of its…

Read More OraSure updated Its Emergency Use Authorization application for lab-based oral SARS-CoV-2 antibody testContinue

FDA approved prosthetic implant for above-the-knee amputations
FDA | Life Science History

FDA approved prosthetic implant for above-the-knee amputations

On Dec. 18, 2020, the FDA approved the Osseoanchored Prostheses for the Rehabilitation of Amputees (OPRA) Implant System,…

Read More FDA approved prosthetic implant for above-the-knee amputationsContinue

FDA approved first oral hormone therapy for teating advanced prostate cancer
FDA | Life Science History

FDA approved first oral hormone therapy for teating advanced prostate cancer

On Dec. 18, 2020, tthe U.S. Food and Drug Administration approved Orgovyx (relugolix) for the treatment of adult…

Read More FDA approved first oral hormone therapy for teating advanced prostate cancerContinue

COVAX announced additional access promising COVID-19 vaccine candidates with global rollout starting 2021
COVID-19 | Life Science History | Vaccine | WHO

COVAX announced additional access promising COVID-19 vaccine candidates with global rollout starting 2021

On Dec. 18, 2020, the World Health Organization (WHO) announced that it had arrangements in place to access…

Read More COVAX announced additional access promising COVID-19 vaccine candidates with global rollout starting 2021Continue

Johnson & Johnson announced agreement with Gavi to supply COVID-19 vaccine candidate to lower-income countries in 2021
COVID-19 | Life Science History | Vaccine

Johnson & Johnson announced agreement with Gavi to supply COVID-19 vaccine candidate to lower-income countries in 2021

On Dec. 18, 2020, Johnson & Johnson announced that its subsidiary Janssen Pharma, will provide up to 500…

Read More Johnson & Johnson announced agreement with Gavi to supply COVID-19 vaccine candidate to lower-income countries in 2021Continue

Investigational COVID-19 therapeutics evaluated in large clinical trials
COVID-19 | Life Science History

Investigational COVID-19 therapeutics evaluated in large clinical trials

On Dec. 17, 2020, NIAID announced that two randomized, controlled Phase 3 clinical trials had begun evaluating investigational…

Read More Investigational COVID-19 therapeutics evaluated in large clinical trialsContinue

NIAID study of Coronavirus infection and multisystem inflammatory syndrome in children began
Life Science History

NIAID study of Coronavirus infection and multisystem inflammatory syndrome in children began

On Dec. 17, 2020, NIAID announced that an observational study had launched to evaluate the short- and long-term…

Read More NIAID study of Coronavirus infection and multisystem inflammatory syndrome in children beganContinue

XPhyto completed successful SARS-COV-2 RT-PCR diagnostic testk kit validation
COVID-19 | Life Science History

XPhyto completed successful SARS-COV-2 RT-PCR diagnostic testk kit validation

On Dec. 17, 2020, XPhyto Therapeutics and 3a-diagnostics announced the successful validation of their point-of-care SARS-CoV-2 (COVID-19) RT-PCR…

Read More XPhyto completed successful SARS-COV-2 RT-PCR diagnostic testk kit validationContinue

Page navigation

Previous PagePrevious 1 … 39 40 41 42 43 … 172 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search